1
Cermenati Laura, Morrison Christopher, Verstraeten William: Liquid acidic hard surface cleaning composition. Procter & Gamble, February 18, 2009: EP2025742-A1 (4 worldwide citation)

The present invention relates to a liquid acidic hard surface cleaning composition comprising an acid system, wherein the acid system comprises formic acid and acetic acid.


2
Morrison Christopher, Robson Barry, Fishleigh Robert: Improvements in or relating to hormones.. Proteus Molecular Design, December 7, 1988: EP0293530-A2 (4 worldwide citation)

An analogue of lutenising hormone-releasing hormone (LHRH) having the amino acid sequence: pGlg-His-Trp-Ser-Tyr-X-Len-Arg-Pro-Gly-Y-Z wherein X represents Gly or a D-amino acid, Y represents one or more amino acid residues, which may be the same of different, and Z represents Cys or Tyr, such that t ...


3

4
Morrison Christopher Andrew, Patterson Steven, Jansen Judit Ester: Speckle particles and compositions containing the speckle particles. Procter & Gamble, May 10, 2000: GB2343456-A (2 worldwide citation)

Cleaning composition speckle particles contain specific crystalline material which is preferably coloured by addition of a dye pigment and/ or a brightener. The speckle particles are used, in particular in laundry and dish washing compositions. The crystalline material may be a hydrated salt, acid, ...


5
Morrison Christopher Andrew: Light reflecting particles. Procter &Amp, Gamble, October 18, 2000: GB2348884-A (1 worldwide citation)

Visible light reflecting particles comprise one or more detergent ingredients and comprising a light reflecting component, which provides that the particle has a specular visible light reflection which is greater in intensity than the specular visible light reflection of the ingredients per se. Pref ...


6
Morrison Christopher, Cermenati Laura, Verstraeten William: Liquid acidic hard surface cleaning composition. Procter & Gamble, July 1, 2009: EP2075325-A1 (1 worldwide citation)

The present invention relates to a liquid acidic hard surface cleaning composition comprising an acid system, wherein the acid system comprises oxalic acid and acetic acid.


7
IBRAHIM PRABHA, ELZEIN ELFATIH, SHENK KEVIN, JIANG ROBERT, ZABLOCKI JEFF, LI XIAOFEN, MORRISON CHRISTOPHER, PERRY THAO, XIAO DENGMING: Partial and full agonists of A1 adenosine receptors, Teilweise oder vollständige A1 Adenosinrezeptoren, Agonistes partiels et complets de récepteurs dadénosine A1. CV THERAPEUTICS, February 1, 2012: EP2412716-A1

Disclosed are novel compounds that are partial and full A 1 adenosine receptor agonists, useful for treating various disease states, in particular tachycardia and atrial flutter, angina, myocardial infarction and hyperlipidemia.


8
Morrison Christopher Andrew, Wilkinson Carole Patricia Deni: Process for preparation of granular detergent composition or component comprising a water-soluble cationic surfactant. Procter & Gamble, November 25, 1998: EP0879876-A1

The invention provides a process which comprises the step of drying an aqueous solution or dispersion, the aqueous solution or dispersion comprising a water-soluble cationic surfactant, in the presence of a drying gas wherein the maximum temperature of the drying gas is less than 250 DEG C. Preferab ...


9
Morrison Christopher Andrew, Keuleers Robby Renilde Francois, Delaere Thomas, Labiano Ros Mercedes: Process for treating hard surface. Procter & Gamble, March 25, 2009: EP2039747-A1

The present invention relates to a process of treating a hard surface with a composition comprising polyalkoxylate trisiloxane. More specifically, it relates to a process of treating an horizontal hard surface, wherein a composition comprising polyalkoxylate trisiloxane is applied onto said hard sur ...


10
Ibrahim Prabha, Campbell Michael, Jiang Robert, Morrison Christopher, Shenk Kevin, Shirley William, Zablocki Jeff, Koltun Dmitry, Natero Reina: Compounds for increasing abca-1 expression useful for treating coronary artery disease and atherosclerosis. Cv Therapeutics, March 16, 2005: EP1513534-A2

The present invention provides compounds that elevate cellular expression of the ABCA-1 gene, promoting cholesterol efflux from cells and increasing HDL levels in the plasma of a mammal, in particular humans. The compounds are useful for treating coronary artery disease.